Bright key facts / Emerging
Molecule proposals return to the lab.
NVIDIA describes Genentech and Amgen drug-discovery workflows using generative AI.
- AI’s role
- NVIDIA says Amgen uses models to propose and evaluate candidates; it describes a Genentech lab-in-the-loop collaboration.
- Documented result
- The page presents named workflow examples, not a treatment result.
- Important limitation
- The reviewed source supplies no Novo Nordisk-specific example and no independently verified faster, lower-cost or patient outcome.